Rethinking patient selection in the era of advanced hybrid closed-loop systems

17:40 – 17:45WelcomeJordan Pinsker (USA)
17:45 – 18:00One-Year Real-Life Use of Control-IQ Compared to Control-IQ Pivotal TrialsBoris Kovatchev (USA)
18:00 – 18:15Rethinking “Candidate Selection” for Control-IQ Hybrid Closed Loop TechnologyGregory Forlenza (USA)
18:15 – 18:30Patient-Selection for Hybrid Closed Loop SystemsKatharine Barnard-Kelly (UK)
18:30 – 18:40 Live Q&A

Jordan Pinsker (USA)
Boris Kovatchev (USA)
Gregory Forlenza (USA)
Katharine Barnard-Kelly (UK)

Join scientists and clinicians who have been closely involved in the development and launch of Control-IQ™ technology for the t:slim X2™ insulin pump as they discuss patient selection in the era of advanced hybrid closed-loop systems. Discussion will include best practices for your clinic and recent patient reported outcomes. Time will be set aside at the end for a live question and answer session.